Tuesday, 20 December 2016

Alzheimer's disease psychosis drug clears mid-stage study: Acadia

(Reuters) - Acadia Pharmaceuticals Inc said on Tuesday its drug to treat psychosis in patients suffering from Alzheimer's disease met its main goal in a mid-stage study.


No comments:

Post a Comment